In particular, pro-inflammatory cytokines such as interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and interleukin-1 beta (IL-1β) are frequently elevated in breast tumors or patient circulation and have been implicated in promoting tumor growth, invasion, metastasis, and therapy resistance. This evidence concerns the gene IL6 and neoplasm.